Allarity Therapeutics, Inc. Securities Fraud Lawsuit: An Investor’s Opportunity
Allarity Therapeutics, Inc. Securities Fraud Lawsuit: An Investor’s Opportunity
LOS ANGELES, Oct. 3, 2024 — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have an opportunity to lead the securities fraud class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) ALLR. Class Period: May 17, 2022 – July 19, 2024 Lead Plaintiff Deadline: November 12, 2024 If you ...










